Steven Milligan
Physician Assistant · Rockingham, NCNPI 1619523628
Payments from drug & device makers
Across 996 payments — averaging $13.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Johnson & Johnson$1K
- Alkermes, Inc.$980
- Teva Pharmaceuticals USA, Inc.$793
- plus $5K from 23 others
What the payments were for
- Food & beverage$13,48899%
- Education$1951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 290 | $3,012 |
| Otsuka America Pharmaceutical, Inc. | 91 | $1,295 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 83 | $1,239 |
| Johnson & Johnson | 56 | $1,127 |
| Alkermes, Inc. | 53 | $980 |
| Teva Pharmaceuticals USA, Inc. | 58 | $793 |
| Indivior Inc. | 43 | $658 |
| Lundbeck LLC | 31 | $431 |
| Corium, LLC | 25 | $428 |
| Sunovion Pharmaceuticals Inc. | 30 | $403 |
| Idorsia Pharmaceuticals US Inc | 21 | $375 |
| Vanda Pharmaceuticals Inc. | 26 | $359 |
| Supernus Pharmaceuticals, Inc. | 42 | $340 |
| Ironshore Pharmaceuticals Inc. | 20 | $331 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $311 |
| Axsome Therapeutics, Inc. | 20 | $260 |
| Avanir Pharmaceuticals, Inc. | 21 | $251 |
| Tris Pharma Inc | 13 | $212 |
| Almatica Pharma LLC | 7 | $152 |
| Braeburn Inc. | 9 | $144 |
| Adlon Therapeutics L.p. | 8 | $130 |
| Merck | 8 | $125 |
| Eisai Inc. | 6 | $85 |
| Neos Therapeutics, LP | 4 | $65 |
| Neurocrine Biosciences, Inc. | 4 | $62 |
| Noven Therapeutics, LLC | 3 | $49 |
| Brainsway USA Inc | 1 | $24 |
| Noven Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$500
- ARISTADA INITIO$125
- VRAYLAR$125
- QUVIVIQ$122
How this compares
$13,683 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 48 | $79,945 |
| Abilify MaintenaAripiprazole | 23 | $66,616 |
| Invega SustennaPaliperidone Palmitate | 18 | $51,290 |
| VraylarCariprazine Hcl | 17 | $28,309 |
| UbrelvyUbrogepant | 14 | $24,372 |
| DayvigoLemborexant | 28 | $10,068 |
| Loreev XrLorazepam | 12 | $9,315 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 88 | $4,415 |
| Vilazodone Hcl | 43 | $4,316 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 45 | $3,823 |
| Quetiapine Fumarate | 83 | $1,298 |
| Hydroxyzine Hcl | 22 | $1,057 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 21 | $958 |
| Fluoxetine Hcl | 54 | $891 |
| Clonazepam | 58 | $812 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $1,295 | $146,56171 claims |
| AbbVieVraylar, Ubrelvy | $3,012 | $52,68131 claims |
| Johnson & JohnsonInvega Sustenna | $1,127 | $51,29018 claims |
| Eisai Inc.Dayvigo | $85 | $10,06828 claims |
| Almatica Pharma LLCLoreev Xr | $152 | $9,31512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Rockingham
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.